Liposomal bupivacaine addition versus standard bupivacaine alone for colorectal surgery: a randomized controlled trial
Keyword(s):
Aim: This study evaluated use of liposomal bupivacaine (LB) versus standard bupivacaine (SB) alone in quadratus lumborum (QL) blocks for laparoscopic colorectal surgery. Materials & methods: In this prospective, randomized controlled trial, patients received QL1 blocks with either LB (40 ml 0.125% SB plus 20 ml of LB) or SB (60 ml of 0.25% SB) with 30 ml per side. Opioid usage, pain scores, side effects and other medications were recorded. Results: For 78 patients (38 LB; 40 SB), all parameters were similar between groups, except that the LB group had a higher 48 h need for metoclopramide. Conclusion: LB provided no analgesic benefit over SB alone for QL blocks. Clinical Trials registration number: NCT03702621
2020 ◽
Vol 62
◽
pp. 109716
◽
2014 ◽
Vol 29
(3)
◽
pp. 353-358
◽
2019 ◽
Vol 54
◽
pp. 61-65
◽
2019 ◽
2015 ◽
Vol 77
(S3)
◽
pp. 1233-1236
◽
2021 ◽
2019 ◽
Vol 44
(3)
◽
pp. 348-353
◽
2021 ◽
Vol Publish Ahead of Print
◽